First-in-Class Alzheimer’s Drug Earns Federal Approval
For Alzheimer’s patients, the long wait is over.
Will Alzheimer’s Drugs Reach the Patients Who Need Them?
![](https://allianceforpatientaccess.org/wp-content/uploads/2023/11/AdobeStock_267911424-scaled-1-1024x683.jpeg)
For the 6 million Americans living with Alzheimer’s disease, the wait for treatment options is almost over. Or is it?